11-77190882-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000409709.9(MYO7A):​c.3924+12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.522 in 1,534,358 control chromosomes in the GnomAD database, including 211,859 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 19657 hom., cov: 32)
Exomes 𝑓: 0.52 ( 192202 hom. )

Consequence

MYO7A
ENST00000409709.9 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.0760

Publications

15 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-77190882-C-T is Benign according to our data. Variant chr11-77190882-C-T is described in ClinVar as Benign. ClinVar VariationId is 43226.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.578 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000409709.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO7A
NM_000260.4
MANE Select
c.3924+12C>T
intron
N/ANP_000251.3
MYO7A
NM_001127180.2
c.3924+12C>T
intron
N/ANP_001120652.1
MYO7A
NM_001369365.1
c.3891+12C>T
intron
N/ANP_001356294.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO7A
ENST00000409709.9
TSL:1 MANE Select
c.3924+12C>T
intron
N/AENSP00000386331.3
MYO7A
ENST00000458637.6
TSL:1
c.3924+12C>T
intron
N/AENSP00000392185.2
MYO7A
ENST00000409619.6
TSL:1
c.3891+12C>T
intron
N/AENSP00000386635.2

Frequencies

GnomAD3 genomes
AF:
0.506
AC:
76584
AN:
151492
Hom.:
19643
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.440
Gnomad AMI
AF:
0.476
Gnomad AMR
AF:
0.588
Gnomad ASJ
AF:
0.381
Gnomad EAS
AF:
0.468
Gnomad SAS
AF:
0.343
Gnomad FIN
AF:
0.618
Gnomad MID
AF:
0.437
Gnomad NFE
AF:
0.530
Gnomad OTH
AF:
0.507
GnomAD2 exomes
AF:
0.518
AC:
87106
AN:
168156
AF XY:
0.506
show subpopulations
Gnomad AFR exome
AF:
0.439
Gnomad AMR exome
AF:
0.635
Gnomad ASJ exome
AF:
0.388
Gnomad EAS exome
AF:
0.483
Gnomad FIN exome
AF:
0.621
Gnomad NFE exome
AF:
0.533
Gnomad OTH exome
AF:
0.500
GnomAD4 exome
AF:
0.524
AC:
724604
AN:
1382756
Hom.:
192202
Cov.:
37
AF XY:
0.519
AC XY:
351809
AN XY:
678500
show subpopulations
African (AFR)
AF:
0.430
AC:
13340
AN:
31000
American (AMR)
AF:
0.625
AC:
21651
AN:
34656
Ashkenazi Jewish (ASJ)
AF:
0.378
AC:
9149
AN:
24224
East Asian (EAS)
AF:
0.477
AC:
17074
AN:
35760
South Asian (SAS)
AF:
0.368
AC:
28911
AN:
78530
European-Finnish (FIN)
AF:
0.617
AC:
30290
AN:
49106
Middle Eastern (MID)
AF:
0.388
AC:
2150
AN:
5540
European-Non Finnish (NFE)
AF:
0.538
AC:
573875
AN:
1066922
Other (OTH)
AF:
0.494
AC:
28164
AN:
57018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
16723
33446
50170
66893
83616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16666
33332
49998
66664
83330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.505
AC:
76627
AN:
151602
Hom.:
19657
Cov.:
32
AF XY:
0.508
AC XY:
37660
AN XY:
74088
show subpopulations
African (AFR)
AF:
0.440
AC:
18117
AN:
41182
American (AMR)
AF:
0.588
AC:
8973
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
1314
AN:
3446
East Asian (EAS)
AF:
0.468
AC:
2404
AN:
5140
South Asian (SAS)
AF:
0.344
AC:
1654
AN:
4808
European-Finnish (FIN)
AF:
0.618
AC:
6531
AN:
10568
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.530
AC:
36013
AN:
67898
Other (OTH)
AF:
0.504
AC:
1061
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1953
3906
5859
7812
9765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
670
1340
2010
2680
3350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.518
Hom.:
55526
Bravo
AF:
0.504

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
2
Autosomal dominant nonsyndromic hearing loss 11 (2)
-
-
2
Autosomal recessive nonsyndromic hearing loss 2 (2)
-
-
2
Usher syndrome type 1 (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
8.5
DANN
Benign
0.68
PhyloP100
0.076
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276285; hg19: chr11-76901927; COSMIC: COSV68686532; API